Hepatitis B Vaccine

Hepatitis B Vaccine: Essential Steps for Protecting At-Risk Infants

Key Takeaways

The Risk of HepB for At-Risk Infants
The Hepatitis B Vaccination Schedule for At-Risk Infants
Key Reminders for Parents and Healthcare Providers
Testing and Follow-Up: The Dried Blood Spot (DBS) Test
Administrative and Financial Considerations
Conclusion
Frequently Asked Questions

Hepatitis B is a serious viral infection that can be passed from mother to child during birth. For infants born to hepatitis B positive mothers, the risk of developing chronic hepatitis B is alarmingly high—up to 90% if left unprotected. Chronic infection can lead to liver cirrhosis, cancer, and lifelong health complications. The good news is that with a precise vaccination schedule and timely follow-up, these risks can be dramatically reduced.

The Hepatitis B Vaccination Schedule for At-Risk Infants

The Six-Dose Pathway

2. Routine Hexavalent Vaccines

Vaccination Schedule Table

Key Reminders for Parents and Healthcare Providers

Register Early and Communicate

Book Appointments in Advance

Monitor and Support

Testing and Follow-Up: The Dried Blood Spot (DBS) Test

Why the DBS Test Matters

At 12 months, a Dried Blood Spot (DBS) test is performed to screen for hepatitis B infection. This test is not for checking immunity, but to confirm that the infant has not become infected despite vaccination.

  • If the test is negative: The child is considered protected, and no further hepatitis B vaccines are needed.
  • If the test is positive: The child will need referral to a specialist for further assessment and management.

How the DBS Test Works

Importance of Timely Testing

Administrative and Financial Considerations

Reimbursement for Monovalent Doses

Documentation and Record-Keeping

Conclusion

The Medicines Management Team offers resources and guidance for both parents and healthcare professionals. Contact your local TMMT representative or visit our website for more information.

Related Blogs